Advances in the Pharmacotherapy of Heart Failure: Type 2 Sodium-Glucose Cotransporter Inhibitors (SGLT2) As a Therapeutic Option. RSD 2023, 12 (3), e12412340502. https://doi.org/10.33448/rsd-v12i3.40502.